Murali Vemula

I am a Scientist and Entrepreneur with a passion to translate basic research findings into commercially viable projects. In my current role as Founder & CEO at Nivarta, Inc., I am leading the efforts to develop a protein therapeutic to treat rare diseases and NAFLD/NASH and identify novel therapeutic targets that are involved in gastric bypass surgery mediated diabetes remission. In the past, I worked as a scientist at Novartis and Proteostasis Therapeutics on discovery & validation of novel drug targets involved in diabetes, obesity, cystic fibrosis, and neurological disorders using cell/molecular biology and bioinformatics methods. I have conducted detailed literature review and evaluated development opportunities from mechanistic, pharmacological, and clinical perspectives. Initially trained as doctoral student at Rutgers University, I completed my postdoctoral fellowship at MGH/Harvard Medical School. Currently, I am pursuing executive MBA at Cornell University. In whole, I bring my experiences in large pharmaceutical & small biotech together with subject matter expertise in science and business as a Venture Fellow at BioExpertNetwork.